NCT07012395: A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- State
- Under way
- Phase
- Phase 2
- People
- 645 planned
- Started
- 27 May 2025
- Primary completion
- Jun 2027
- Arms
- Intervention Specific Appendix - SPY003: Part A, Intervention Specific Appendix - SPY003 Dosing Regimen 1: Part B, Intervention Specific Appendix - SPY003 Dosing Regimen 2: Part B
- Results
- None posted
- 27 May 2025: Trial started
- 10 Jun 2025: Trial registered